Sage Therapeutics Inc Cash Flow Quality Index

Latest as of December 2020: 1.04x

Sage Therapeutics Inc cash flow quality index. Sage Therapeutics Inc (SAGE) has a Cash Flow Quality Index of 1.04x as of December 2020. Operating cash flow of $1.01 Billion exceeds net income of $974.89 Million, indicating high earnings quality where cash backs reported profits. See SAGE FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

1.04x

Operating CF / Net Income

Operating Cash Flow

$1.01 Billion

USD

Net Income

$974.89 Million

USD

Data as of

Dec 2020

Most recent filing

Cash Flow Quality Index of Sage Therapeutics Inc (2020–2020)

Cash flow quality index of Sage Therapeutics Inc from 2020 to 2020. Historical Cash Flow Quality Index for Sage Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Sage Therapeutics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Sage Therapeutics Inc Cash Flow Quality Index by Year (2020–2020)

Sage Therapeutics Inc cash flow quality index by year from 2020 to 2020. Year-by-year earnings quality comparison for Sage Therapeutics Inc. For the full cash flow conversion analysis, see Sage Therapeutics Inc (SAGE) cash conversion ratio.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change
2020	1.10x	$664.28 Million	$606.07 Million	—

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.